PanAMusheyevDBockelmanDLoebSKabarritiAE. Assessment of artificial intelligence chatbot responses to top searched queries about cancer. JAMA Oncol. 2023;9(10):1437-1440. doi:10.1001/JAMAONCOL.2023.2947
2.
AyersJWPoliakADredzeM, et al. Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum. JAMA Intern Med. 2023;183(6):589-596. doi:10.1001/JAMAINTERNMED.2023.1838
3.
CharnockDShepperdSNeedhamGGannR. DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health. 1999;53(2):105. doi:10.1136/JECH.53.2.105
4.
ShoemakerSJWolfMSBrachC. Development of the Patient Education Materials Assessment Tool (PEMAT): a new measure of understandability and actionability for print and audiovisual patient information. Patient Educ Couns. 2014;96(3):395-403. doi:10.1016/J.PEC.2014.05.027
5.
GumilarKEIndraprastaBRHsuYC, et al. Disparities in medical recommendations from AI-based chatbots across different countries/regions. Sci Rep. 2024;14(1):1-10. doi:10.1038/s41598-024-67689-0
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
